𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: Relation to disease activity and effect of chemotherapy

✍ Scribed by Dr. H. Hasselbalch; P. Junker; K. Hørslev-Petersen; I. Lisse; K. D. Bentsen


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
748 KB
Volume
33
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Serum type III procollagen peptide in al
✍ Massimo Colombo; Giorgio Annoni; Maria Francesca Donato; Dario Conte; Dino Marti 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB

To assess the value of type I11 procollagen peptide (sPIIIP) as a marker of hepatic fibrosis, sera from 73 patients with alcohol-related liver disease and 30 patients with idiopathic hemochromatosis (IHC) were studied by a specific radioimmunoassay. sPIIIP was increased in 87% of 30 patients with ci

Serum type III procollagen peptide conce
✍ Arthur J. McCullough; William N. Stassen; Russell H. Wiesner; Albert J. Czaja 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 666 KB

To analyze the correlations between the presence of cirrhosis and hepatocellular inflammation and the serum concentrations of the amino-terminal peptide of procollagen type 111 in chronic liver disease, we measured prodlagen type 1 1 1 concentrations in paired serum samples from 46 patients (17 had

Serum type III procollagen peptide, type
✍ Yoshikazu Murawaki; Yujiro Ikuta; Masahiko Koda; Hironaka Kawasaki 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 719 KB

To assess the clinical value of serum biochemical markers, the aminoterminal peptide of type III procollagen, type IV collagen 7S domain, the central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases, as a marker of hepatic fibrosis, we measured these four serum markers in